ArticleJournal of nutrition and metabolism2025
Chinese Sausage Simulates High Calorie-Induced Obesity In Vivo, Identifying the Potential Benefits of Weight Loss and Metabolic Syndrome of Resveratrol Butyrate Monomer Derivatives.
Article in Journal of nutrition and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Anti-inflammatory mechanism of resveratrol's Triglyceride-lowering effect in hyperlipidemia: a meta-analysis integrated network pharmacology and molecular dynamics simulation.Clinical and experimental medicine · 2025Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study examined the health benefits of 3-O-butanoylresveratrol (ED4), a monoester derivative of resveratrol butyrate esters. Using a high-calorie diet model simulation with Chinese sausage, ED4 was tested against changes in physiological indices like body weight (BW), body fat, blood pressure, and SCFA levels (stools and serum) in rats. This study found that the obesity-inducing model utilizing sausage as a high-calorie diet worked, and that supplementing rats with ED4 (20 mg/kg BW/day) for 5 weeks inhibited BW increase and body fat buildup. Blood lipid and SCFA dysregulation improved significantly. In addition, ED4 effectively increased PPAR-γ and decreased SREBP-1C mRNA expression, preventing fat accumulation and overproduction. A novel food-driven relationship between gut microbiota and adipose was found, promoting health. Our findings showed that ED4 supplementation exacerbated metabolic abnormalities caused by high-calorie diets and reduced body fat. Notably, these metabolic benefits were enhanced through the involvement of intestinal microbiota.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.